Effects of PTMs on mAb–Ligand Binding Assessed by SEC with LC-MS/MS and Correlation to Affinity and Potency Measurements

Abstract Therapeutic monoclonal antibodies (mAbs) accumulate a wide variety of chemical and post-translational modifications (PTMs) during production, storage, and in vivo after administration to patients. In this study, we applied size exclusion chromatography (SEC) to isolate subpopulations of different binding stoichiometries of mAb-target complexes after subjecting the mAbs to stresses relevant to manufacturing and physiological conditions. The SEC-fractionated subpopulations were analyzed by LC-MS/MS peptide mapping to identify critical PTMs that decrease ligand binding. Modifications in complementarity determining regions (CDRs) at light chain (LC) N33, heavy chain (HC) W103, and HC N104 were observed to be enriched in the SEC mAb fractions that did not bind the ligand, indicating these modifications diminish binding to the ligand. Total deamidation of N33 resulted in a moderate decrease in binding; however, when delineated into the individual D33 and isoD33 components via electron-transfer dissociation (ETD), only the isoD product was observed to significantly impact binding. Surface plasmon resonance (SPR), bead-based receptor–ligand binding, and cell-based receptor activation assays were utilized to measure the functional impact of the identified PTMs, which indicated a slight decrease in binding capacity and potency for the stressed mAbs, mirroring the trend observed by the SEC and LC-MS methods. The combination of the SEC assay and the traditional binding and potency assays provides a more complete view of the site-specific and modification-specific attributes in the context of their functional impact on decreased mAb–ligand binding and overall potency.

Authors

Institutions

Publication Details

Journal
Journal of the American Society for Mass Spectrometry
Published
2026-11-17
DOI
https://doi.org/10.1021/jasms.6c00331
Primary Topic
Protein purification and stability
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Effects of PTMs on mAb–Ligand Binding Assessed by SEC with LC-MS/MS and Correlation to Affinity and Potency Measurements

Kelli Matthies, Andrew B. Dykstra, Prashant N. Jethva, Joshua M. Tokuda et al.
3 links
Journal of the American Society for Mass Spectrometry
Protein purification and stability
article

Effects of PTMs on mAb–Ligand Binding Assessed by SEC with LC-MS/MS and Correlation to Affinity and Potency Measurements

Kelli Matthies, Andrew B. Dykstra, Prashant N. Jethva, Joshua M. Tokuda, Nicholas Clark, Daniel W. Woodall, Alexander A. Shcherbakov, Jonathan E. Phillips, Pani Kiaei, Pavel V. Bondarenko, David Fong, Brian Bennett, Hong Yu Wang, Qing Chen
article en

Abstract

Abstract Therapeutic monoclonal antibodies (mAbs) accumulate a wide variety of chemical and post-translational modifications (PTMs) during production, storage, and in vivo after administration to patients. In this study, we applied size exclusion chromatography (SEC) to isolate subpopulations of different binding stoichiometries of mAb-target complexes after subjecting the mAbs to stresses relevant to manufacturing and physiological conditions. The SEC-fractionated subpopulations were analyzed by LC-MS/MS peptide mapping to identify critical PTMs that decrease ligand binding. Modifications in complementarity determining regions (CDRs) at light chain (LC) N33, heavy chain (HC) W103, and HC N104 were observed to be enriched in the SEC mAb fractions that did not bind the ligand, indicating these modifications diminish binding to the ligand. Total deamidation of N33 resulted in a moderate decrease in binding; however, when delineated into the individual D33 and isoD33 components via electron-transfer dissociation (ETD), only the isoD product was observed to significantly impact binding. Surface plasmon resonance (SPR), bead-based receptor–ligand binding, and cell-based receptor activation assays were utilized to measure the functional impact of the identified PTMs, which indicated a slight decrease in binding capacity and potency for the stressed mAbs, mirroring the trend observed by the SEC and LC-MS methods. The combination of the SEC assay and the traditional binding and potency assays provides a more complete view of the site-specific and modification-specific attributes in the context of their functional impact on decreased mAb–ligand binding and overall potency.

Journal of the American Society for Mass Spectrometry
Amgen (United States) (US)
Amgen
Good health and well-being
Protein purification and stability
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon